Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients - Tabular View

Tracking Information

First Received Date ^ICMJE

August 7, 2007

Last Updated Date

August 7, 2007

Start Date ^ICMJE

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

effect of furosemid inhalation on dyspnea

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

Official Title ^ICMJE

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study

Brief Summary

to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure

Detailed Description

Study Phase

Phase III

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Supportive Care, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Crossover Assignment

Condition ^ICMJE

Bronchiolitis

Intervention ^ICMJE

Drug: furosemide

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

Primary Completion Date

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Patients with a history of exposure to sulfur mustard with a complaint of dyspnea

Exclusion Criteria:

A contraindication for furosemide use;
An accompanying disease in which other drugs effective for dyspnea were used

Gender

Male

Ages

32 Years to 83 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Iran, Islamic Republic of

Administrative Information

NCT ID ^ICMJE

NCT00512811

Responsible Party

Study ID Numbers ^ICMJE

121a25

Study Sponsor ^ICMJE

Baqiyatallah Medical Sciences University

Collaborators ^ICMJE

Investigators ^ICMJE

Study Chair:

Mostafa Ghanei, MD

Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran

Information Provided By

Baqiyatallah Medical Sciences University

Verification Date

August 2007

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP